MiNK Therapeutics (INKT) SEC Filings & 10K Form

$0.91
-0.02 (-2.15%)
(As of 05/9/2024 ET)

Recent MiNK Therapeutics SEC Filings

DateFilerForm TypeView
04/29/2024
4:25 PM
MiNK Therapeutics (Filer)
Form DEF 14A
03/21/2024
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
5:00 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:05 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
5:05 PM
ARMEN GARO H (Filed by)
MiNK Therapeutics (Subject)
Form SC 13D
02/14/2024
7:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:00 PM
Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:00 PM
MiNK Therapeutics (Issuer)
van Dijk Marcus Antonius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:05 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:05 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:05 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:11 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
3:15 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:49 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
7:18 PM
Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:26 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
8:15 PM
Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:00 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:01 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:01 PM
Baldoni John (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:02 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:04 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2023
4:53 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
4:15 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
6:44 AM
MiNK Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/10/2023
6:26 AM
MiNK Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
2:45 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
7:20 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:03 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:07 PM
Baldoni John (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:11 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:13 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:39 PM
Baldoni John (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:40 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:41 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:42 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Crypto 9-5 Escape Plan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
06/02/2023
6:43 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
4:12 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4/A
05/26/2023
4:28 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4/A
05/26/2023
4:29 PM
ARMEN GARO H (Reporting)
MiNK Therapeutics (Issuer)
Form 4/A
05/11/2023
7:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INKT) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners